Covidogram as a simple tool for predicting severe course of COVID-19: population-based study
Open Access
- 23 February 2021
- Vol. 11 (2), e045442
- https://doi.org/10.1136/bmjopen-2020-045442
Abstract
Objectives COVID-19 might either be entirely asymptomatic or manifest itself with a large variability of disease severity. It is beneficial to identify early patients with a high risk of severe course. The aim of the analysis was to develop a prognostic model for the prediction of the severe course of acute respiratory infection. Design A population-based study. Setting Czech Republic. Participants The first 7455 consecutive patients with COVID-19 who were identified by reverse transcription-PCR testing from 1 March 2020 to 17 May 2020. Primary outcome Severe course of COVID-19. Result Of a total 6.2% of patients developed a severe course of COVID-19. Age, male sex, chronic kidney disease, chronic obstructive pulmonary disease, recent history of cancer, chronic heart failure, acid-related disorders treated with proton-pump inhibitors and diabetes mellitus were found to be independent negative prognostic factors (Area under the ROC Curve (AUC) was 0.893). The results were visualised by risk heat maps, and we called this diagram a ‘covidogram’. Acid-related disorders treated with proton-pump inhibitors might represent a negative prognostic factor. Conclusion We developed a very simple prediction model called ‘covidogram’, which is based on elementary independent variables (age, male sex and the presence of several chronic diseases) and represents a tool that makes it possible to identify—with a high reliability—patients who are at risk of a severe course of COVID-19. Obtained results open clinically relevant question about the role of acid-related disorders treated by proton-pump inhibitors as predictor for severe course of COVID-19.Funding Information
- The Czech Republic Operational Programme eHealth and Rare Disease (CZ.03.4.74/0.0/0.0/15_025/)
This publication has 26 references indexed in Scilit:
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinGastroenterology, 2019
- Reply to: Proton Pump Inhibitors and Long-term Risk of Community-acquired Pneumonia in Older AdultsJournal of the American Geriatrics Society, 2018
- Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older AdultsJournal of the American Geriatrics Society, 2018
- A calibration hierarchy for risk models was defined: from utopia to empirical dataJournal of Clinical Epidemiology, 2016
- Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD)Circulation, 2015
- Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2010